Logo-ijdrc
Original Article

1. Blockade of CD155 and Interleukin-6 Suppresses Breast Cancer Cell Growth
Atefeh Khodakarami ORCID, Samira Darvishi, Hadi Hassannia, Mohammad Sadeghi, Sana Esmaeeli, Vida Hashemi, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh* ORCID
Int J Drug Res Clin. 2023;1: e10 | Published on: 2023 Jun 22. doi: 10.34172/ijdrc.2023.e10
Article
PDF
Full Text
XML
Cited By:
0
Original Article

2. Smac Mimetic BV6 Increases the Sensitivity of Cancer Cells to Doxorubicin Through Suppression of Apoptosis Inhibitors
Maryam Farajzadeh, Mohammad-Salar Hosseini, Koosha Koorehpaz, Sanam Nami, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh*
Int J Drug Res Clin. 2025;3: e5 | Published on: 2025 Mar 01. doi: 10.34172/ijdrc.2025.e5
Article
PDF
XML
Cited By:
0
Original Article

3. Inhibitory Effects of Diosgenin on Breast Cancer Cell Progression through Regulation of Metastatic Gene Expression
Majid Montazer ORCID, Elham Jangi, Mehran Molavand ORCID, Bahman Yousefi* ORCID, Amir Valizadeh* ORCID
Int J Drug Res Clin. 2025;3: e20 | Published on: 2025 Nov 22. doi: 10.34172/ijdrc.2025.e20
Article
PDF
XML
Cited By:
Original Article

4. Imipramine Sensitizes Glioblastoma Cells to Temozolomide via PI3K/Akt Inhibition and Mitochondrial Apoptosis Induction
Nazanin Bazazzadeh ORCID, Mehran Molavand, Bahman Yousefi, Mohammad Shimia* ORCID
Int J Drug Res Clin. 2026;4: e9101 | Published on: 2026 Apr 13. doi: 10.34172/ijdrc.9101
Article
PDF
XML
Cited By:
Review Article

5. Decoding Wnt Signaling in Cancer Therapy Resistance: Current Perspectives
Mehran Molavand ORCID, Amir Valizadeh, Azita Asadi, Bahman Yousefi* ORCID
Int J Drug Res Clin. 2026;4: e9112 | Published on: 2026 May 02. doi: 10.34172/ijdrc.9112
Article
PDF
XML
Cited By:

Platinum* Open Access

*This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website. 

 

 

Following:

 

Indexing & Abstracting: